ZA201303136B - Methods and composition for treating hiv-associated diarrhea - Google Patents

Methods and composition for treating hiv-associated diarrhea

Info

Publication number
ZA201303136B
ZA201303136B ZA2013/03136A ZA201303136A ZA201303136B ZA 201303136 B ZA201303136 B ZA 201303136B ZA 2013/03136 A ZA2013/03136 A ZA 2013/03136A ZA 201303136 A ZA201303136 A ZA 201303136A ZA 201303136 B ZA201303136 B ZA 201303136B
Authority
ZA
South Africa
Prior art keywords
composition
methods
treating hiv
associated diarrhea
diarrhea
Prior art date
Application number
ZA2013/03136A
Other languages
English (en)
Inventor
Enoch Bortey
William Forbes
Steven King
Pravin Chaturvedi
Original Assignee
Salix Pharmaceuticals Ltd
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201303136(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Salix Pharmaceuticals Ltd, Napo Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Ltd
Publication of ZA201303136B publication Critical patent/ZA201303136B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA2013/03136A 2010-10-31 2013-04-29 Methods and composition for treating hiv-associated diarrhea ZA201303136B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19
PCT/US2011/058549 WO2012058664A1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea

Publications (1)

Publication Number Publication Date
ZA201303136B true ZA201303136B (en) 2016-01-27

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/03136A ZA201303136B (en) 2010-10-31 2013-04-29 Methods and composition for treating hiv-associated diarrhea

Country Status (20)

Country Link
US (4) US8962680B2 (cg-RX-API-DMAC7.html)
EP (1) EP2632550B1 (cg-RX-API-DMAC7.html)
JP (2) JP6063385B2 (cg-RX-API-DMAC7.html)
CN (2) CN107595836A (cg-RX-API-DMAC7.html)
AU (1) AU2011320155B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013010774A2 (cg-RX-API-DMAC7.html)
CA (1) CA2816416C (cg-RX-API-DMAC7.html)
DK (1) DK2632550T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP13012650A (cg-RX-API-DMAC7.html)
ES (1) ES2635435T3 (cg-RX-API-DMAC7.html)
HK (1) HK1249036A1 (cg-RX-API-DMAC7.html)
HU (1) HUE035393T2 (cg-RX-API-DMAC7.html)
MX (1) MX348184B (cg-RX-API-DMAC7.html)
PE (1) PE20140036A1 (cg-RX-API-DMAC7.html)
PH (1) PH12013500857A1 (cg-RX-API-DMAC7.html)
PL (1) PL2632550T3 (cg-RX-API-DMAC7.html)
PT (1) PT2632550T (cg-RX-API-DMAC7.html)
RU (1) RU2597746C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012058664A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201303136B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ595679A (en) 2006-05-01 2013-04-26 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
CA3025084C (en) 2006-05-01 2021-10-12 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
PL2632550T3 (pl) 2010-10-31 2017-10-31 Napo Pharmaceuticals Inc Sposoby i kompozycja do leczenia biegunki związanej z HIV
EP2928560A4 (en) * 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
WO2020180424A1 (en) 2019-03-04 2020-09-10 Iocurrents, Inc. Data compression and communication using machine learning
AU2020454132A1 (en) * 2020-06-19 2023-02-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
JP4195728B2 (ja) 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ,インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2007002173A1 (en) * 2005-06-22 2007-01-04 University Of Massachusetts Hiv-1 protease inhibitors, and methods of making and using them
CA2633417A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
CA3025084C (en) 2006-05-01 2021-10-12 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
NZ595679A (en) * 2006-05-01 2013-04-26 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
EA023814B1 (ru) 2009-08-26 2016-07-29 Гленмарк Фармасьютикалс Лтд. Способ получения полимерных композиций на основе проантоцианидина для фармацевтических форм
WO2011044167A1 (en) 2009-10-06 2011-04-14 University Of California, San Francisco Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
PL2632550T3 (pl) 2010-10-31 2017-10-31 Napo Pharmaceuticals Inc Sposoby i kompozycja do leczenia biegunki związanej z HIV
BR112013018688B1 (pt) 2011-01-27 2021-08-24 Napo Pharmaceuticals, Inc Método de produção de uma composição polimérica de proantocianidina
MY197454A (en) 2011-12-22 2023-06-19 Napo Pharmaceuticals Inc Non-enteric pharmaceutical composition comprising crofelemer
EP2928560A4 (en) 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA

Also Published As

Publication number Publication date
US9585868B2 (en) 2017-03-07
JP2017019806A (ja) 2017-01-26
EP2632550B1 (en) 2017-05-03
PH12013500857A1 (en) 2018-01-17
JP6063385B2 (ja) 2017-01-18
RU2597746C2 (ru) 2016-09-20
AU2011320155B2 (en) 2016-02-25
CN107595836A (zh) 2018-01-19
AU2011320155A1 (en) 2013-05-09
HUE035393T2 (en) 2018-05-02
US8962680B2 (en) 2015-02-24
EP2632550A1 (en) 2013-09-04
JP2013540826A (ja) 2013-11-07
PL2632550T3 (pl) 2017-10-31
RU2013123794A (ru) 2014-12-10
DK2632550T3 (en) 2017-08-07
PT2632550T (pt) 2017-08-02
MX2013004873A (es) 2013-08-21
ES2635435T3 (es) 2017-10-03
US20120184605A1 (en) 2012-07-19
US20150190367A1 (en) 2015-07-09
CA2816416C (en) 2020-02-11
CA2816416A1 (en) 2012-05-03
CN103370101A (zh) 2013-10-23
HK1249036A1 (zh) 2018-10-26
JP6310971B2 (ja) 2018-04-11
BR112013010774A2 (pt) 2017-03-21
WO2012058664A1 (en) 2012-05-03
MX348184B (es) 2017-06-02
PE20140036A1 (es) 2014-01-31
US20120107370A1 (en) 2012-05-03
EP2632550A4 (en) 2014-04-23
ECSP13012650A (es) 2013-10-31
US20140294903A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
ZA201303136B (en) Methods and composition for treating hiv-associated diarrhea
ZA201303423B (en) Compositions and methods for treating myelofibrosis
SG2014010706A (en) Method and composition
GB201016001D0 (en) Composition and method
IL239918A0 (en) Preparations for the treatment of colitis
IL238416A0 (en) Preparations and methods for the treatment of diseases caused by protein pathology
EP2608778A4 (en) COMPOSITIONS AND METHODS FOR TREATING BONE ANOMALIES
PL2613776T3 (pl) Kompozycja oraz sposób naprawy i regeneracji mięśni
SI2552484T1 (sl) Postopki in sestavki za znižanje ravni paratiroidnega hormona
AP3941A (en) Materials and methods for treating diarrhea
IL216146A0 (en) Methods and compositions for treating lupus
IL225483A0 (en) The compositions and methods for the treatment of neoplasia
IL232648A0 (en) Preparations and methods for treating glioma
GB201003531D0 (en) Composition and method
EP2928560A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
GB201008364D0 (en) Composition and method
GB201106433D0 (en) Composition and method
ZA201305497B (en) Methods and compositions for preventing and treating osteoarthritis
GB201008843D0 (en) Method and composition
PL2606032T3 (pl) Kompozycja i sposoby terapii glejakaep
GB2500357B (en) Combination and composition for treating obesity
EP2632432A4 (en) COMPOSITION AND METHOD FOR TREATING LESIONS
EP2603610A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING A LUPUS
ZA201502944B (en) A composition and method for treating substrates
GB201116803D0 (en) Method and compositions for treating cutaneous verrucae